تجاوز إلى المحتوى الرئيسي
User Image

Farid Shokry Ataya

Associate Professor

Teaching Staff Member

كلية العلوم
2A26 Building 5
المنشورات
مقال فى مجلة
2022

Association of Alzheimer’s disease with genetic variants of Apolipoprotein E, Clusterin, TNF-α and IL-6 among elderly Saudis. Current Pharmaceutical Biotechnology . 2022, 23, (15): 1893 - 1902 (Impact factor 2.837, Q3), ISSN: 1389-2010, eISSN: 1873-4316 D

Background: In the wake of the warning by WHO that the prevalence of dementia may have a rise of 125% in the Middle East by 2050, identification of the genetic risk factors in Arab populations is urgent.

Objectives: To investigate the association of Single Nucleotide Polymorphisms (SNPs) in apolipoprotein E (ApoE), clusterin (CLU), tumor necrotic factor- α (TNF-α) and interleukin-6 (IL-6) genes, with risk of Alzheimer's disease (AD) in Saudi Arabian participants.

Methods: A total of 42 Saudi AD patients and 23 age-matched control participants were genotyped for eight SNPs: rs429358, rs7412 (ApoE); rs11136000, rs1532278 (CLU); rs1800629, rs1799724 (TNF-α) and rs1800796, rs1800795(IL-6), by RT-PCR using the TaqMan assay. Serum concentrations of amyloid beta peptide 1-40(Aβ1-40), amyloid beta peptide 1-42(Aβ1- 42), CLU and some other biochemical markers were measured.

Results: A significant increase (p=0.004) in the serum CLU level was detected in the AD group (340.4 ± 74.6) compared with control group (265.0 ± 80.9). For rs1532278 (CLU), genotype GA was significantly higher in AD patients (57.1%) than in the control participants (26.1%), [p=0.024, OR = 4.00, 95% CI (1.20-13.28)]. For the ApoE SNP rs7412, 40.4% of patients carried a TT genotype, whereas it was completely absent in the controls [p = 0.020, OR = 30.53, 95% CI (1.73 - 540.05)].For rs429358 (ApoE), patients showed a significantly increased frequency of the TC genotype [p = 0.006, OR = 9.33, 95% CI (1.89-46.19)] and TT [p = 0.045, OR = 19.76, 95% CI (1.07-366.0)] genotype than controls. AD patients with CC genotype for ApoE rs429358 had significantly lower levels of Aβ1-40 (p=0.04) in AD patients than controls. Carriers of genotype GG for rs1800629 (TNF-α) showed significantly higher levels of serum IL-6 (p = 0.04) in AD patients.

اسم الناشر
Current Pharmaceutical Biotechnology
رقم المجلد
23
رقم الانشاء
15
الصفحات
1893 - 1902
مزيد من المنشورات
publications

Glutathione S. transferases (GSTs; EC. 2.5.1.18) are a large family of multifunctional enzymes that play crucial roles in the metabolism and inactivation of a broad range of xenobiotic compounds.…

بواسطة Fereniki Perperopoulou, Nirmal Poudel, Anastassios C. Papageorgiou, Farid Ataya and Nikolaos E
2022
تم النشر فى:
MPDI
publications

Background: In the wake of the warning by WHO that the prevalence of dementia may have a rise of 125% in the Middle East by 2050, identification of the genetic risk factors in Arab populations is…

بواسطة Saba Abdi, Amani Ahmed Alghamdi, Nouf Nasser Abduallah AlGhunaim, Reem Muteb Almutairi, Farid Shokry Ataya, Mohammed Ghouse Ahmed Ansari, Syed Danish Hussain, Mohammad Masoud, Abir Alamro,Othman T. Almutairi, Nasser M. Al-Daghri, Taim Abdullah Muayqil
2022
تم النشر فى:
Current Pharmaceutical Biotechnology